Charlotte W. Collns, Director at BioScrip, Inc. (BIOS), bought 300 shares at $3.20 ($960) on 2006-09-15, disclosed to the SEC on 2006-09-18.
Open-market purchase of $960 BIOS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.